The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts the Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer

Jiajun Liu; Rengyun Liu; Xiaopei Shen; Guangwu Zhu; Biao Li; Mingzhao Xing

doi:10.2967/jnumed.119.227652

OtherClinical Investigations (Human)

The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts the Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer

Jiajun Liu, Rengyun Liu, Xiaopei Shen, Guangwu Zhu, Biao Li and Mingzhao Xing

Journal of Nuclear Medicine August 2019, jnumed.119.227652; DOI: https://doi.org/10.2967/jnumed.119.227652

Jiajun Liu

1 Department of Nuclear Medicine, Rui Jin Hospital, Shanghai Jiao Tong University, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rengyun Liu

2 Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University School of Medicine

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xiaopei Shen

2 Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University School of Medicine

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Guangwu Zhu

2 Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University School of Medicine

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Biao Li

1 Department of Nuclear Medicine, Rui Jin Hospital, Shanghai Jiao Tong University, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mingzhao Xing

2 Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University School of Medicine

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Article Figures & Data

Additional Files

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 5

May 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts the Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts the Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer

Jiajun Liu, Rengyun Liu, Xiaopei Shen, Guangwu Zhu, Biao Li, Mingzhao Xing

Journal of Nuclear Medicine Aug 2019, jnumed.119.227652; DOI: 10.2967/jnumed.119.227652

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts the Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer

Jiajun Liu, Rengyun Liu, Xiaopei Shen, Guangwu Zhu, Biao Li, Mingzhao Xing

Journal of Nuclear Medicine Aug 2019, jnumed.119.227652; DOI: 10.2967/jnumed.119.227652

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Genetic drivers of etiologic heterogeneity in thyroid cancer
Molecular and Proteomic Profiles of Radioiodine Refractory Papillary Thyroid Cancer
Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma
Bone Mineral Density: Clinical Relevance and Quantitative Assessment

Google Scholar

Keywords

endocrine
Oncology: Endocrine
oncology: head and neck
BRAF V600E
TERT promoter mutation
radioiodine refractoriness
recurrence
thyroid cancer

Main menu

User menu

Search

The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts the Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer

Article Figures & Data

Additional Files

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

Similar Articles

Keywords